High Grade Meningiomas: Current Therapy Based on Tumor Biology
Atypical (WHO grade II) and malignant meningiomas (WHO Grade III) are a rare subset of primary intracranial tumors. Due to the high recurrence rate after surgical resection and radiotherapy, there has been a recent interest in exploring other systemic treatment options for these refractory tumors. R...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/79815 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: High Grade Meningiomas: Current Therapy Based on Tumor Biology
- Diagnosis and Grading of Meningiomas
- Radiation Therapy in the Management of Meningiomas
- Current Advances and Concepts in the Treatment of Meningioma
- Automatic and explainable grading of meningiomas from histopathology images
- Management of High-Grade Meningioma: Present, Past and Promising Future
- Efficient Meningioma Tumor Segmentation Using Ensemble Learning